diabetes specific nutrition formula (dsnf) for …ley sh, hamdy o, mohan v, hu fb. lancet....

33
Diabetes Specific Nutrition Formula (DSNF) For Diabetes Management & Cost Reduction Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director Inpatient Diabetes Program, Joslin Diabetes Center Associate Professor of Medicine, Harvard Medical School, Boston, MA

Upload: others

Post on 04-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Diabetes Specific Nutrition

Formula (DSNF) For Diabetes

Management & Cost Reduction

Osama Hamdy, MD, PhD, FACE

Medical Director, Obesity Clinical Program,Director Inpatient Diabetes Program,

Joslin Diabetes CenterAssociate Professor of Medicine,

Harvard Medical School, Boston, MA

Page 2: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks
Page 4: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Summary of Meta-analysis of Prospective Studies of

Nutrient Intake and Glycemic Variables and Type 2 Diabetes

Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007.

DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks are comparison of extreme categories, except DHA/EPA (per 250 mg per day increase) and

alpha-linolenic acid (per 0.5 g per day).

All nutrients and glycemic variables were assessed from dietary intake, except vitamin D for which blood 25hydroxyvitamin D was used.

Page 5: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Summary of Meta-analysis of Prospective Cohort Studies on

Food and Beverage Intake and Type 2 Diabetes

Relative risks are comparison of extreme categories, except for processed meat (per 50 g per day increase), unprocessed red meat and

fish or seafood (per 100 g per day), white rice (per each serving per day), whole grains (per three servings per day), sugar-sweetened

beverages in European cohorts (per 336 g per day), and alcohol (22 g per day for men and 24 g per day for women with abstainers)

Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007.

Page 6: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Dietary intervention for Patients with Type 2 Diabetes

Carbs to 40-45%

Glycemic index

Protein intake 1.0-1.5 gm/kgFiberMUFA

Saturated fat from meat Sodium

Natural food (dinner

menus and snacks) and

Calorie Replacement

Page 7: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Diabetes-Specific Formulas (DSFs) are designed to improve glucose control

1. Elia M, et al. Diabetes Care. 2005;28(9):2267–2279.

2. Mesejo A, et al. Crit Care. 2015;19:390. doi: 10.1186/s13054-015-1108-1.

Diabetes-Specific Standard

Defined nutrient composition to enable better

glycemic control

May compromise glycemic control

in patients with diabetes

Modified carbohydrate (low glycemic)High in rapidly digested carbohydrate (high

glycemic)

Modified fat: favors monounsaturated (MUFA) fatsLower fat

May reduce need for additional insulin to maintain

good glycemic control1,2

May require more attention to maintain glucose

control

Clinically demonstrated efficacy in people with

diabetes

Limited efficacy demonstrated in people with

diabetes

Page 8: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

– Total estimated cost of diabetes in

2012 was $245 billion (41% up from

2007), with $176 billion direct cost

and 69 billion reduced productivity

– Largest component of medical

expenditures attributed to diabetes

was hospital inpatient care (~43%%

of costs)

Diabetes Care. 2013; 36(4): 1033-1046

Page 9: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Differences in Resource Utilization Between Diabetic Patients

Receiving Diabetes-Specific Nutrition Formula Versus Standard

Nutrition Formula In US Hospitals

Hamdy O et al. JPEN J Parenter Enteral Nutr. 2014; 38(2 Suppl):86S-91S.

Page 10: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Objective and Methods

Design

– Retrospective review of all inpatients within Premier Research Database

– N=>500 geographically diverse hospitals

– Comparisons made between:

●Diabetic patients fed diabetes specific formula (DSNF)

●Diabetic patients fed standard nutrition (STD)

Hamdy O et al. JPEN J Parenter Enteral Nutr. 2014; 38(2 Suppl):86S-91S.

Page 11: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Population Flow

Diabetic Population

8.8 million discharges (2000-2009)

Fed either STD or DSF

193,473 discharges

Tube Fed

85,481 discharges

DSNF

37,171 discharges

Standard Formula

48,310 discharges

Hamdy O et al. JPEN J Parenter Enteral Nutr. 2014; 38(2 Suppl):86S-91S.

Page 12: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Results

Per patient Tube Fed DSNFs

Average Length of Hospital Stay -0.9 days

Total Hospital Costs -$2,586

* Average LOS and hospital cost statistically significant at P < 0.001

Savings from feeding DSF rather than STD formula

• Feeding DSF to patients with diabetes results in significant* improvement in patient efficiency and cost

of care

Hamdy O et al. JPEN J Parenter Enteral Nutr. 2014; 38(2 Suppl):86S-91S.

Per patient Oral Fed DSNFs

Average Length of Hospital Stay -0.17 days

Total Hospital Costs -$1,356

Page 13: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

$20,000

$22,000

$24,000

$26,000

$28,000

STDNutrition

Room andBoard

Pharmacy NursingLabor

Supply Other DSFNutrition

Adj

uste

d C

ost p

er P

atie

nt ($

)

Using DSNF drives reduction in room & board, pharmacy, and labor costs for tube fed patients

Note: Analysis adjusted the Other cost consistent with total cost savings since all costs independently modeled. Other costs include Surgery, Lab, Diagnostic Imaging, and Cardiology. All cost values statistically significant at P < 0.0001 except TF Central Supply Costs (P < 0.003). N for each sample population > 30k

Tube Fed PWD - $2,586 total savings per patient

($1,257)

($341)($354)

($82) (~$552)

$26,769

$24,183

Page 14: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Expert recommendations for DSF

“Regarding enteral nutritional therapy, diabetes-specific formulas appear to be superior to standard formulas in controlling postprandial glucose, A1C and the insulin response.”

“Based on this available evidence, the ESPEN expert group endorses the utilization of DSFs for nutritional support of people with obesity and diabetes.”

Clin Nutr. 2017 Apr;36(2):355-363

Page 15: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

DSN = diabetes-specific nutrition.

*Data logarithmically transformed for analysis.

Tatti P, et al. Med J Nutrition Metab. 2010;3:65-69.

Changes in Weight

We

igh

t (k

g)

70

75

80

85

90

95

Baseline 3 Months 6 Months

>5% wt loss DSN- <5% wt loss DSN+

P=0.000*

n=96<5% wt loss (n=38)

>5% wt loss (DSN-) (n=40)

DSN (n=29)

Significant Reduction in Weight By DSF in Patients With Diabetes in Association With Reduction in

Glycemic Variability

Page 16: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Significant Reduction in HbA1c By DSF in Patients With Diabetes in Association With Reduction in

Glycemic Variability

Changes in HbA1c

Hb

A1

C

6

7

8

9

Baseline 3 Months 6 Months

>5% wt loss <5% wt loss

n=96 <5% wt loss (n=38)

>5% wt loss (n=40)

<5% wt loss (n=38)

DSN n=29)

P=0.000*

7 1.5

6.7 1.5

P=0.000*

-0.3%

A1c

*Data logarithmically transformed for analysis.

Tatti P, et al. Med J Nutrition Metab. 2010;3:65-69.

Page 17: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Strong Correlation Between Meal Replacements and Weight Loss (Look AHEAD Study)

Number in the bar is mean number

of MRs used in that quartile

Per

cent

age

Wei

ght L

oss

(%)

Reproduced with permission from Wadden TA et al. Obesitiy 2009; 17:713-722

1st 2nd 3rd 4th

-5.9%-7.2%

-9.4%

-11.2%117 277 406 608MRs

MRs = meal replacements

Page 18: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Estimated Cost-Saving After Why WAIT Program for 1 Year

Cost Saving

[1% wt loss]

Co

st s

avi

ng

pe

r ye

ar

(-3.6%)

(-5.8%)

(-27%)

(-44%)

Estimated Saving in WW

[7.6% wt loss]

YU AP et al. Curr Med Res Opin. 2007;23(9):2157-69

Health Care Cost Diabetes Related Cost

Page 19: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Time in Minutes

60

100

140

180

220

0 30 60 90 120 150 180 210 240

Pla

sm

a G

lucose in m

g/d

l

Effect of Different Diabetes-specific Formulas Versus Oatmeal on Plasma Glucose

Area Under the Curve (AUC)

Each meal is 200 Kcal

*p<0.05, **p<0.01, ***p<0.001 Versus Oatmeal†P<0.05 , ††P<0.01, †††P<0.001 Between Glucerna & Ultra-Glucose

control

AUC 0-240 (Area Under the Curve)

Oatmeal = 5933.3

Glucerna = 1684.2***

Ultra-Glucose Control = 3351.1***

N=22

******

Oat Meal

Formula 1

Formula 2

200 Calorie Meals

Mottalib A. et al. Nutrients. 2016; 8(7) pii: E443.

Page 20: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Minutes

Insulin

uIU

/m

L

Positive AUC0-120 was significantly higher Formula 2 than after OM (p=0.02)

-5

0

5

10

15

20

25

0 30 60 90 120 150 180 210 240

Oat Meal

Formula 1

Formula 2

Mottalib A. et al. Nutrients. 2016; 8(7) pii: E443.

Page 21: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

-5

0

5

10

15

20

0 30 60 90 120 150 180 210 240

Minutes

GLP-1

pg

/m

L

Positive AUC0-240 was significantly higher after both formulas than after OM (p<0.001 for both)

Oat Meal

Formula 1

Formula 2

Mottalib A. et al. Nutrients. 2016; 8(7) pii: E443.

Page 22: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Minutes

PYY

pg

/m

L

Positive AUC0-240 was significantly higher after both formulas than after OM (p<0.001 for both)

-20

-10

0

10

20

30

40

0 30 60 90 120 150 180 210 240

Oat Meal

Formula 1

Formula 2

Mottalib A. et al. Nutrients. 2016; 8(7) pii: E443.

Page 23: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Minutes

Amylin (active)

pg

/m

L

-4

-2

0

2

4

6

8

0 30 60 90 120 150 180 210 240

Oat Meal

Formula 1

Formula 2

Mottalib A. et al. Nutrients. 2016; 8(7) pii: E443.

Page 24: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Nutrition Path Study

Page 25: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Structured

Meal Plan

Calorie

Distribution

• 40-45% from

carbohydrates

• 30-35% from fat with

<10% from saturated fat

• 1-1.5 gm/kg of body

weight from protein

• 14g fiber/1000 Kcal

Snack

ListsDinner MenusDiabetes-Specific

Nutrition Formula

1-3 times/day to replace

equivalent calories

Includes 100

and 200

calorie

snacks

17 choices with

detailed ingredients,

cooking instructions

and nutrition facts

Mottalib A et al. Nutr J. 2018;17(1):42. doi:10

Page 26: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Nutrition Therapy

Group BGroup A Group C

Individualized Meal Plan

StructuredMeal Plan

Meet RD Meet RD Meet RD

StructuredMeal Plan

+

Weekly phone callMottalib A, Hamdy O. et al. Nutr J. 2018;17(1):42. doi:10

Page 27: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

0.01

-0.63

-0.67

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0.4

0 8 16

Group A

Group B

Group C

A1C is significantly different between groups over time (p=0.0006)* p<0.01 and ** p<0.001 compared to baseline

**

**

*

**

Weeks

A1

C %

A1C

Mottalib A et al. Nutr J. 2018;17(1):42. doi:10

Page 28: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Weeks

kg

Weight loss

-0.95

-3.5

-2.7

-5

-4

-3

-2

-1

0

0 8 16

Group A

Group B

Group C

*

*

*

* p<0.001 compared to baseline

*

Mottalib A et al. Nutr J. 2018;17(1):42. doi:10

Page 29: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

-10

-8

-6

-4

-2

0

2

Waist Circumference Visceral Fat

Group A

Group B

Group C

**

% C

ha

ng

e f

rom

ba

se

lin

e

Abdominal Adiposity

*

* p<0.05 and ** p<0.01 compared to baseline

**

Mottalib A et al. Nutr J. 2018;17(1):42. doi:10

Page 30: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Properties/EffectGLP-1 Receptor

Agonists1,2

DPP-4 Inhibitors1,2

Insulin production +++ ++

Amylin NO NO

GLP-1PYY

-NO

+NO

Gastric emptying Delayed No effect

Food intake No effect

Body weight No effect

Visceral Fat NO NO

Side effects Nausea, vomiting Minimal

Incretin Therapies: Major Differences

1. DeFronzo RA et al. Curr Med Res Opin. 2008; 24:2943-2952.

2. Drucker DJ &Nauck MA. Lancet. 2006;368:1696-1705.

MNT with DSF

++

+

++++

NO

NO

Page 31: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

“Medical Nutrition Therapy (MNT) throughout the course of a structured weight

loss plan, is strongly recommended”

“Studies have demonstrated that a variety of eating plans, varying in macronutrient composition, can be used effectively and safely in short term (1-2 years) to achieve weight loss in people with diabetes. This includes structured low-calorie meal plans

that include meal replacements”

ADA Standards of Diabetes Care 2019. Diabetes Care. 2019, 1 (supplement 1) Mottalib A et al. Nutr J. 2018;17(1):42. doi:10

Page 32: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Clinical evidence from RCTs indicate that DSNF, as suggested medical food, improves outcomes in patients with diabetes

.

1. Elia M, et al. Diabetes Care. 2005;28(9):2267–2279. 2. Alish CJ, et al. Diabetes Technol Ther. 2010;12(6):419–425. 3. Mesejo A, et al. Crit Care. 2015;19:390. doi.10.1186/s13054-015-1108-1.

2. 4. Vaisman N, et al. Clin Nutr. 2009;28(5):549555. 5. Voss AC, et al. Nutrition. 2008;24(10):549–555.

• Better postprandial glucose control• Increase GLP-1 and satiety hormones• Lower A1C • Reduce glycemic variability• Reduce body weight • Reduced insulin requirements• Reduce LOS and hospital cost

GLP-1=glucagon-like peptide; HbA1c=glycated hemoglobin.

Page 33: Diabetes Specific Nutrition Formula (DSNF) For …Ley SH, Hamdy O, Mohan V, Hu FB. Lancet. 2014;383(9933):1999-2007. DHA=docosahexaenoic acid EPA-eicosapentaenoic acid. Relative risks

Thank You